immuno-oncology

BioNTech
Manufacturing

BioNTech works to diversify supply base ahead of oncology launch

BioNTech is making plans to debut on the commercial oncology scene. Part of that effort involves mapping out a larger manufacturing footprint.
Eric Sagonowsky May 5, 2025 10:36am
layoffs job cuts fired exit restructuring layoff reduction

Coherus loses commercial chief amid exit from biosimilar space

Apr 23, 2025 11:19am
BMS

BMS follows Roche, AstraZeneca into first-line liver cancer

Apr 11, 2025 1:53pm
tuberculosis vaccine

ImmunityBio, SII win FDA nod to help combat BCG shortage

Feb 19, 2025 9:01am
Focus magnify target strategy

Agenus to offer CDMO services, lay off staffers in latest reorg

Dec 5, 2024 7:51am
merger virtual handshake

Coherus sells Neulasta biosimilar to Intas for up to $558M

Dec 3, 2024 4:16pm